Source author record

Xuelin Huang

Explore this author’s publications, collaborators and research topics. This catalog record has not been claimed by its author.

ResearcherUnclaimed source record

Methodology

Catalog footprint

Research overview

2works

1topics

4close collaborators

Actions

Is this your work?

Open graph Browse papers

preprint2022arXiv

Comparison of Effect Size Measures for Mediation Analysis of Survival Outcomes with Application to the Framingham Heart Study

There is an increasing trend of research in mediation analysis for survival outcomes. Such analyses help researchers to better understand how exposure affects disease outcomes through mediators. However, due to censored observations in survival outcomes, it is not straightforward to extend mediation analysis from linear models to survival outcomes. In this article, we extend a mediation effect size measure based on $R^2$ in linear regression to survival outcomes. Due to multiple definitions of $R^2$ for survival models, we compare and evaluate five $R^2$ measures for mediation analysis. Based on extensive simulations, we recommend two $R^2$ measures with good operating characteristics. We illustrate the utility of the $R^2$ -based mediation measures by analyzing the mediation effects of multiple lifestyle risk factors on the relationship between environmental exposures and time to coronary heart disease and all-cause mortality in the Framingham Heart Study.

preprint2022arXiv

Evidence synthesis with reconstructed survival data

We present a general approach to synthesizing evidence of time-to-event endpoints in meta-analyses of aggregate data (AD). Our work goes beyond most previous meta-analytic research by using reconstructed survival data as a source of information. A Bayesian multilevel regression model, called the "meta-analysis of reconstructed survival data" (MARS), is introduced, by modeling and integrating reconstructed survival information with other types of summary data, to estimate the hazard ratio function and survival probabilities. The method attempts to reduce selection bias, and relaxes the presumption of proportional hazards in individual clinical studies from the conventional approaches restricted to hazard ratio estimates. Theoretically, we establish the asymptotic consistency of MARS, and investigate its relative efficiency with respect to the individual participant data (IPD) meta-analysis. In simulation studies, the MARS demonstrated comparable performance to IPD meta-analysis with minor deviation from the true values, suggesting great robustness and efficiency achievable in AD meta-analysis with finite sample. Finally, we applied MARS in a meta-analysis of acute myeloid leukemia to assess the association of minimal residual disease with survival, to help respond to FDA's emerging concerns on translational use of surrogate biomarker in drug development of hematologic malignancies.

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.